Jaguar Health Inc. (JAGX)
Jaguar Health Statistics
Share Statistics
Jaguar Health has 1.26M shares outstanding. The number of shares has increased by -86.58% in one year.
| 1.26M |
| -86.58% |
| 39.02% |
| 0% |
| n/a |
| 405 |
| 0.31% |
Short Selling Information
The latest short interest is 32.26K, so 3.17% of the outstanding shares have been sold short.
| 32.26K |
| 3.17% |
| 3.27% |
| 1 |
Valuation Ratios
The PE ratio is -0.19 and the forward PE ratio is -1.22. Jaguar Health's PEG ratio is 0.
| -0.19 |
| -1.22 |
| 0.64 |
| 0.3 |
| 1.02 |
| -0.25 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Jaguar Health.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 5.01.
| 1.63 |
| 1.11 |
| 5.01 |
| -1 |
| -1.23 |
| -133.47 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $238,551.02 |
| $-785,551.02 |
| 49 |
| 0.22 |
| 0.19 |
Taxes
| -759K |
| 1.93% |
Stock Price Statistics
The stock price has increased by -87.81% in the last 52 weeks. The beta is 0.7, so Jaguar Health's price volatility has been higher than the market average.
| 0.7 |
| -87.81% |
| 6.48 |
| 19.72 |
| 31.52 |
| 131,954 |
Income Statement
In the last 12 months, Jaguar Health had revenue of 11.69M and earned -38.49M in profits. Earnings per share was -130.69.
| 11.69M |
| 9.73M |
| -30.83M |
| -38.49M |
| -36.66M |
| -39.02M |
| -130.69 |
Balance Sheet
The company has 8M in cash and 36.53M in debt, giving a net cash position of -28.52M.
| 8M |
| 36.53M |
| -28.52M |
| -346.48M |
| 51.46M |
| 2.23M |
Cash Flow
In the last 12 months, operating cash flow was -29.38M and capital expenditures -231K, giving a free cash flow of -29.61M.
| -29.38M |
| -231K |
| -29.61M |
| -100.55 |
Margins
Gross margin is 83.27%, with operating and profit margins of -263.76% and -329.3%.
| 83.27% |
| -263.76% |
| -335.79% |
| -329.3% |
| -313.65% |
| -263.76% |
| -253.36% |
Dividends & Yields
JAGX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for JAGX is $60, which is 1450.4% higher than the current price. The consensus rating is "Buy".
| $60 |
| 1450.4% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Mar 24, 2025. It was a backward split with a ratio of 1:25.
| Mar 24, 2025 |
| backward |
| 1:25 |
Scores
| -11.94 |
| 4 |